Regenerative Medicine News

Pluristem Completes Large Scale Cell Therapy Formulation for Commercial and ...
Equities.com
7, 2012 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, announced today the Company has successfully completed the integration and testing of its new scaled-up ...​